Logo image of ALNOV.PA

NOVACYT (ALNOV.PA) Stock Price, Quote, News and Overview

EPA:ALNOV - Euronext Paris - Matif - FR0010397232 - Common Stock - Currency: EUR

0.45  +0.01 (+1.47%)

ALNOV.PA Quote, Performance and Key Statistics

NOVACYT

EPA:ALNOV (8/5/2025, 7:00:00 PM)

0.45

+0.01 (+1.47%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High1.59
52 Week Low0.42
Market Cap31.78M
Shares70.63M
Float70.41M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)09-25 2025-09-25
IPO10-12 2012-10-12


ALNOV.PA short term performance overview.The bars show the price performance of ALNOV.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15 -20 -25

ALNOV.PA long term performance overview.The bars show the price performance of ALNOV.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of ALNOV.PA is 0.45 EUR. In the past month the price decreased by -4.26%. In the past year, price decreased by -16.2%.

NOVACYT / ALNOV Daily stock chart

ALNOV.PA Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
4AB.DE ABBVIE INC 18.74 303.47B
AMG.DE AMGEN INC 14.31 138.38B
GIS.DE GILEAD SCIENCES INC 14.56 121.35B
VX1.DE VERTEX PHARMACEUTICALS INC N/A 85.96B
1REGN.MI REGENERON PHARMACEUTICALS 12.33 52.62B
ARGX.BR ARGENX SE 78.13 35.77B
22UA.DE BIONTECH SE-ADR N/A 22.98B
IDP.DE BIOGEN INC 8.28 16.84B
1BIIB.MI BIOGEN INC 8.3 16.66B
1MRNA.MI MODERNA INC N/A 9.25B
0QF.DE MODERNA INC N/A 9.07B
ABVX.PA ABIVAX SA N/A 4.58B

About ALNOV.PA

Company Profile

ALNOV logo image Novacyt SAS is a diagnostics company, which engages in the business of developing, producing, and selling vitro and molecular diagnostic tests and products for a wide range of infectious diseases. The company is headquartered in Velizy-Villacoublay, Ile-De-France. The company went IPO on 2012-10-12. The firm develops and markets solutions dedicated to the field of liquid-based cytology and molecular biology. The company provides diagnostic products used in oncology, microbiology, haematology, and serology testing. The firm develops secure automated cytology named NovaPrep Processor System. The company offers a solution of cytological sampling to help in the detection of precancerous and cancerous lesions. The company creates bottles specifically dedicated to the optimization of cell collection. The Company’s range of products includes Bottle Gyn and No Gyn Bottle.

Company Info

NOVACYT

131 Boulevard Carnot, Le Vesinet

Velizy-Villacoublay ILE-DE-FRANCE FR

Employees: 240

ALNOV Company Website

ALNOV Investor Relations

Phone: 33139465104

NOVACYT / ALNOV.PA FAQ

What is the stock price of NOVACYT today?

The current stock price of ALNOV.PA is 0.45 EUR. The price increased by 1.47% in the last trading session.


What is the ticker symbol for NOVACYT stock?

The exchange symbol of NOVACYT is ALNOV and it is listed on the Euronext Paris - Matif exchange.


On which exchange is ALNOV.PA stock listed?

ALNOV.PA stock is listed on the Euronext Paris - Matif exchange.


What is NOVACYT worth?

NOVACYT (ALNOV.PA) has a market capitalization of 31.78M EUR. This makes ALNOV.PA a Nano Cap stock.


How many employees does NOVACYT have?

NOVACYT (ALNOV.PA) currently has 240 employees.


What are the support and resistance levels for NOVACYT (ALNOV.PA) stock?

NOVACYT (ALNOV.PA) has a support level at 0.44 and a resistance level at 0.46. Check the full technical report for a detailed analysis of ALNOV.PA support and resistance levels.


Should I buy NOVACYT (ALNOV.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does NOVACYT (ALNOV.PA) stock pay dividends?

ALNOV.PA does not pay a dividend.


When does NOVACYT (ALNOV.PA) report earnings?

NOVACYT (ALNOV.PA) will report earnings on 2025-09-25.


What is the Price/Earnings (PE) ratio of NOVACYT (ALNOV.PA)?

NOVACYT (ALNOV.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.68).


ALNOV.PA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ALNOV.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ALNOV.PA. While ALNOV.PA seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ALNOV.PA Financial Highlights

Over the last trailing twelve months ALNOV.PA reported a non-GAAP Earnings per Share(EPS) of -0.68. The EPS decreased by -49.44% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -59.12%
ROE -87.21%
Debt/Equity 0.22
Chartmill High Growth Momentum
EPS Q2Q%-21.43%
Sales Q2Q%27.82%
EPS 1Y (TTM)-49.44%
Revenue 1Y (TTM)84.82%

ALNOV.PA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 37% to ALNOV.PA. The Buy consensus is the average rating of analysts ratings from 7 analysts.


Ownership
Inst Owners0.05%
Ins Owners0.19%
Short Float %N/A
Short RatioN/A
Analysts
Analysts37.14
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A